Amneal launches Taytulla generic Taysofy

Taytulla and its generic equivalents had a market value of roughly $124.4 million in the 12 months ended June 2021, according to IQVIA.
Levy
text

Amneal is introducing norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules 1 mg/20 mcg, to be marketed as Taysofy.

The product is the generic of Abbvie's oral contraceptive brand Taytulla.

Taytulla and its generic equivalents had a market value of roughly $124.4 million in the 12 months ended June 2021, according to IQVIA.

Taysofye is packaged in cartons containing 5 unit-of-use 28-day blister packs. Each blister pack contains 24 days of active therapy and 4 days of ferrous fumarate supplements.

X
This ad will auto-close in 10 seconds